| Financial Year |
March 31 2023 |
| Monetary Funds |
287,762,453.40 |
| Held-for-trading Financial Assets |
4,505,243.01 |
| Notes Receivable |
7,482,850.00 |
| Accounts Receivable |
1,102,803,751.67 |
| Advances to Suppliers |
22,284,411.38 |
| Other Receivables |
6,760,491.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
264,679,809.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
43,688,155.23 |
| Total Current Assets |
1,739,967,165.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
104,727,156.18 |
| Investment Properties |
-- |
| Fixed Assetes |
778,202,826.62 |
| Under-construction Projects |
290,932,094.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
50,223,817.15 |
| R&D expenses |
29,076,368.25 |
| Goodwill |
13,433,638.57 |
| Long-Term Deferred and Prepaid Expenses |
12,255,334.49 |
| Deferred Income Tax Assets |
84,541,017.20 |
| Other Non-Current Assets |
26,664,934.04 |
| Sub-Total of Non-Current Assets |
1,430,826,276.98 |
| Total Assets |
3,170,793,442.57 |
| Short-Term Loans |
199,634,819.25 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,000,000.00 |
| Accounts Payable |
274,892,554.63 |
| Accounts Received In Advance |
6,993,150.00 |
| Employee Compensation Payable |
37,389,146.48 |
| Taxes Payable |
2,663,819.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
20,933,962.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,604,570.80 |
| Other Current Liabilities |
10,391,929.65 |
| Sub-Total of Current Liabilities |
698,054,504.75 |
| Long-term Loans |
126,599,991.60 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
23,206,614.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
166,634,790.08 |
| Total Liabilities |
864,689,294.83 |
| Paid-In Capital(Or Share Stock) |
354,605,865.00 |
| Capital Surplus |
1,210,890,442.62 |
| Surplus Reserve |
80,849,357.82 |
| LESS:Treasury Stock |
44,519,514.13 |
| Undistributed Profits |
663,428,946.36 |
| Minority Stockholder's Interest |
28,569,109.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,277,535,038.01 |
| Owner's Equity（Stockholder's Equity） |
2,306,104,147.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,170,793,442.57 |
